Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Tiliacora triandra leaf extract** is a botanical extract derived from the leaves of *Tiliacora triandra*, a medicinal plant used traditionally in Thailand. Based on the provided preclinical publication, it is being investigated as a neuroprotective and cognition-enhancing agent for memory impairment related to Alzheimer's disease. In a scopolamine-induced cognitive impairment rat model, the extract improved performance in behavioral memory tests and was associated with reduced acetylcholinesterase activity, reduced malondialdehyde levels, increased antioxidant enzyme activity, and increased hippocampal neuronal density, suggesting a multifactorial mechanism involving cholinergic modulation and attenuation of oxidative stress rather than a single defined molecular target. No specific commercial developer, manufacturer, brand name, or clinical-stage development program is established from the provided evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tiliacora triandra leaf extract.